“We have terminated the purchase agreement with Blair Wellness due to the failure of certain closing conditions to be met prior to our specified termination date,” said Charlie Bachtell, Cresco's CEO & co-founder stated. “We will continue to look for other avenues to expand our footprint in Maryland, and execute our strategy of going deep in meaningful, material states.”

Previously, details noted the transaction would imply a 1.8x 2021 revenue multiple, satisfied through the payment of cash and a twenty-four (24) month promissory note. It was meant to be completed on a cash-free, debt-free basis with a mutually agreed-upon normalized target level of working capital.

The Blair Wellness acquisition was originally expected to close during Q4 2021. There are no termination fees associated with the transaction.

More recent news from Cresco Labs:

Cresco Labs Wraps Up $80M Acquisition Of PA-Based Laurel Harvest, Boosting Cannabis Cultivation

Cresco Labs Honored Clio Cannabis Award For Cannabis-Focused Social Justice Documentary

Cresco Labs Completes $90M Acquisition Of Three High-Performing PA Cannabis Dispensaries

Price Action

Cresco Labs shares closed Tuesday market session 1.34% lower at $6.82 per share.

Photo: Courtesy of Cresco Labs